Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: May 18, 2011

Drug Name Review Type Class Manufacturer
Dulera New Drug Appeal Beta Adrenergic/Glucocorticoid Merck
Seroquel PDL Appeal Atypical Antipsychotic Astra Zeneca
Seroquel XR PDL Appeal Atypical Antipsychotic Astra Zeneca